BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/18/2020 5:58:43 AM | Browse: 879 | Download: 1956
 |
Received |
|
2020-07-10 12:13 |
|
Peer-Review Started |
|
2020-07-10 12:13 |
|
First Decision by Editorial Office Director |
|
2020-10-06 16:39 |
|
Return for Revision |
|
2020-10-06 16:39 |
|
Revised |
|
2020-10-16 04:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-10-30 10:29 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-10-30 22:41 |
|
Articles in Press |
|
2020-10-30 22:41 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-12-14 01:24 |
|
Publish the Manuscript Online |
|
2020-12-18 05:58 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Cory Higley, Christine C Hsu, Coleman Smith, Sandeep Nadella and Alexander T. Lalos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Cory Higley, Consultant, Attending Doctor, Department of Medicine, MedStar Georgetown University Hospital, 3800 Reservoir Rd NW
PHC 5, Washington, DC 20007, United States. cory.higley@gunet.georgetown.edu |
| Key Words |
Sofosbuvir/velpatasvir/voxilaprevir; Hepatitis C; Liver transplant; Direct-acting antiviral; Drug-drug interactions; Case report |
| Core Tip |
There have been limited reports published on the use of sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) for the treatment of hepatitis C virus in post-liver transplant patients who had previous direct-acting antiviral failure prior to transplant. Herein, we present what we believe to be the largest case series of SOF/VEL/VOX use in these patients and highlight its efficacy and safety. More so, we discuss potential drug-drug interactions between SOF/VEL/VOX and common immunosuppression regimens. |
| Publish Date |
2020-12-18 05:58 |
| Citation |
Higley C, Hsu CC, Smith C, Nadella S, Lalos A. Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports. World J Hepatol 2020; 12(12): 1341-1348 |
| URL |
https://www.wjgnet.com/1948-5182/full/v12/i12/1341.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v12.i12.1341 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
